World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
70041
World Ranking
1977
National Ranking
1121

Overview

Michael L. Blute is affiliated with Harvard University in the United States. Their research primarily centers on medicine, with a notable focus on pulmonary and respiratory medicine, surgery, oncology, molecular biology, and urology.

Their main research topics include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Urological Disorders and Treatments
  • Urologic and reproductive health conditions

Frequent co-authors collaborating with Michael L. Blute include:

  • Douglas M. Dahl
  • Adam S. Feldman
  • Andrew Gusev
  • Matthew Wszolek
  • Chin-Lee Wu

They have published multiple papers in a range of venues, with several appearing repeatedly in specific journals. Common publication venues are:

  • The Journal of Urology (6 publications)
  • Urologic Oncology Seminars and Original Investigations (4 publications)
  • Urologic Clinics of North America (3 publications)
  • Oncogene (2 publications)
  • Asian Journal of Urology (2 publications)

Recent published papers by Michael L. Blute include:

  • "Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus", 2023, Urologic Clinics of North America
  • "Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy", 2021, The Journal of Urology
  • "Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing", 2020, Oncogene
  • "Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification", 2021, Urologic Oncology Seminars and Original Investigations
  • "Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis", 2020, Cancer Medicine

Best Publications

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.

    Inderbir S. Gill;Louis R. Kavoussi;Brian R. Lane;Michael L. Blute

  • Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

    John C. Cheville;Christine M. Lohse;Horst Zincke;Amy L. Weaver

  • Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

    W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

  • An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

    R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong

  • Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

    Wko Lau;ML Blute;AL Weaver;VE Torres

  • Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

    Horst Zincke;Joseph E. Oesterling;Michael L. Blute;Erik J. Bergstralh

  • Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;M B S Christine Lohse

  • Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy

    R. Houston Thompson;Brian R. Lane;Christine M. Lohse;Bradley C. Leibovich

  • Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy

    R. Houston Thompson;Stephen A. Boorjian;Christine M. Lohse;Bradley C. Leibovich

  • Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Michael L. Blute;Bradley C. Leibovich;Christine M. Lohse;John C. Cheville

  • PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    R. Houston Thompson;Haidong Dong;Christine M. Lohse;Bradley C. Leibovich

  • Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome

    John F. Ward;Jeffrey M. Slezak;Michael L. Blute;Erik J. Bergstralh

  • Evidence for a prostate cancer susceptibility locus on the X chromosome.

    Jianfeng Xu;Deborah Meyers;Diha Freije;Sarah Isaacs

  • Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery

    Seth E. Lerner;Craig A. Hawkins;Michael L. Blute;Andreas Grabner

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA can open doors to a wide range of online healthcare degrees and flexible career options. Many students begin with alternative pathways before committing to medical school. For example, those who start as registered nurses might benefit from asn to np programs that help bridge the gap toward becoming a nurse practitioner.

Interest in preventative care also continues to rise. If you're passionate about diet and wellness, online nutrition degrees provide a solid foundation for a career in nutritional science or dietetics.

For those focused on leadership or hospital management, it's essential to choose programs with strong credentials. Look for cahme accredited online MHA programs to ensure high academic standards and employer recognition.

Finally, working nurses seeking to advance without onsite requirements can opt for online rn to bsn programs without clinicals. These flexible options allow for continued employment while furthering education. Each of these pathways helps diversify your healthcare career opportunities.

Best Scientists Citing Michael L. Blute

Trending Scientists

Recently Published Articles